CAS: 1170613-55-4
1-Penten-3-one, 1-(4-fluorophenyl)-2-methyl-, oxime, (1E,3E)-
CAS:1170613-55-4
Formula:
C12H14FNO
Purity:
95%
Color and Shape:
Solid
Molecular weight:
207.2441
Ref: IN-DA000DMY
100mg | 110.00 € | ||
250mg | 197.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
A-967079
CAS:1170613-55-4
Formula:
C12H14FNO
Purity:
≥ 98%
Color and Shape:
White, off-white or tan powder
Molecular weight:
207.24
Ref: 7W-GK2181
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
A-967079
CAS:1170613-55-4
A 967079 is a potent, selective, and bioavailable inhibitor of the TRPA1 channel, with IC50 …
Formula:
C12H14FNO
Purity:
98.34% - 99.75%
Color and Shape:
Solid
Molecular weight:
207.24
Ref: TM-T7205
5mg | 54.00 € | ||
10mg | 73.00 € | ||
25mg | 145.00 € | ||
50mg | 245.00 € | ||
100mg | 419.00 € | ||
1mL*10mM (DMSO) | 65.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
(1E,3E)-1-(4-Fluorophenyl)-2-methyl-1-penten-3-one oxime
CAS:1170613-55-4
Purity:
95%
Molecular weight:
207.24g/mol
Ref: 54-PC520753
25mg | 180.00 € | ||
50mg | 280.00 € | ||
100mg | 466.00 € | ||
250mg | 855.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
(1E,3E)-1-(4-Fluorophenyl)-2-methyl-1-penten-3-one Oxime
Controlled ProductCAS:1170613-55-4
Applications (1E,3E)- 1-(4-Fluorophenyl)-2-methyl-1-penten-3-one Oxime is a transient receptor potential ankyrin 1 (TRPA1) antagonist and has …
Formula:
C12H14FNO
Color and Shape:
Neat
Molecular weight:
207.244
Ref: TR-F595440
100mg | 1,589.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
(1E,3E)-1-(4-Fluorophenyl)-2-methyl-1-penten-3-one oxime
CAS:1170613-55-4
(1E,3E)-1-(4-Fluorophenyl)-2-methyl-1-penten-3-one oxime is a novel painkiller that has been shown to be effective in acute …
Formula:
C12H14FNO
Purity:
Min. 95%
Molecular weight:
207.24 g/mol
Ref: 3D-FF95054
1mg | To inquire | ||
2mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025